BerGenBio AS is a biotechnology company founded by researchers at the department of biomedicine, University of Bergen; it is dedicated to deliver specialized cutting-edge research and development services to the global biotechnology and pharmaceutical industry. BerGenBio offers this by providing access to its unique patented CellSelect RNAi technology. This will increase the efficiency of drug development, by reducing time to market, R&D costs and increase success rate. The experienced and dedicated team has a strong track record and BerGenBio has already proven demand with a customer collaboration-contract with a major pharmaceutical company.